Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Islet Transplantation in T1D Kidney Allograft Recipients
NCT00888628Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- May 2009
- Primary completion
- Aug 2014
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of donislecel in type 1 diabetes mellitus (T1D), sponsored by Massachusetts General Hospital. Started May 2009; status: completed.
02
Drugs
donislecel
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00888628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00888628.